Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Levopropoxyphennapsilat
2. Prestwick0_001054
3. Prestwick1_001054
4. Prestwick2_001054
5. Prestwick3_001054
6. Bspbio_001008
7. Spbio_002934
8. Bpbio1_001110
9. Chembl4303291
10. Chebi:94397
11. Hms1571c10
12. Hms2098c10
13. Hms3715c10
14. Ccg-221054
15. Ncgc00180923-01
16. Sr-01000872689
17. Sr-01000872689-1
18. Q27166247
19. [4-(dimethylamino)-3-methyl-1,2-diphenylbutan-2-yl] Propanoate;naphthalene-2-sulfonic Acid
| Molecular Weight | 547.7 g/mol |
|---|---|
| Molecular Formula | C32H37NO5S |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 10 |
| Exact Mass | 547.23924445 g/mol |
| Monoisotopic Mass | 547.23924445 g/mol |
| Topological Polar Surface Area | 92.3 Ų |
| Heavy Atom Count | 39 |
| Formal Charge | 0 |
| Complexity | 688 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 2 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
ABOUT THIS PAGE
39
PharmaCompass offers a list of Regretos API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Regretos manufacturer or Regretos supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Regretos manufacturer or Regretos supplier.
PharmaCompass also assists you with knowing the Regretos API Price utilized in the formulation of products. Regretos API Price is not always fixed or binding as the Regretos Price is obtained through a variety of data sources. The Regretos Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A LEVOPROPOXYPHENE NAPSYLATE ANHYDROUS manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of LEVOPROPOXYPHENE NAPSYLATE ANHYDROUS, including repackagers and relabelers. The FDA regulates LEVOPROPOXYPHENE NAPSYLATE ANHYDROUS manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. LEVOPROPOXYPHENE NAPSYLATE ANHYDROUS API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A LEVOPROPOXYPHENE NAPSYLATE ANHYDROUS supplier is an individual or a company that provides LEVOPROPOXYPHENE NAPSYLATE ANHYDROUS active pharmaceutical ingredient (API) or LEVOPROPOXYPHENE NAPSYLATE ANHYDROUS finished formulations upon request. The LEVOPROPOXYPHENE NAPSYLATE ANHYDROUS suppliers may include LEVOPROPOXYPHENE NAPSYLATE ANHYDROUS API manufacturers, exporters, distributors and traders.
LEVOPROPOXYPHENE NAPSYLATE ANHYDROUS Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of LEVOPROPOXYPHENE NAPSYLATE ANHYDROUS GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right LEVOPROPOXYPHENE NAPSYLATE ANHYDROUS GMP manufacturer or LEVOPROPOXYPHENE NAPSYLATE ANHYDROUS GMP API supplier for your needs.
A LEVOPROPOXYPHENE NAPSYLATE ANHYDROUS CoA (Certificate of Analysis) is a formal document that attests to LEVOPROPOXYPHENE NAPSYLATE ANHYDROUS's compliance with LEVOPROPOXYPHENE NAPSYLATE ANHYDROUS specifications and serves as a tool for batch-level quality control.
LEVOPROPOXYPHENE NAPSYLATE ANHYDROUS CoA mostly includes findings from lab analyses of a specific batch. For each LEVOPROPOXYPHENE NAPSYLATE ANHYDROUS CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
LEVOPROPOXYPHENE NAPSYLATE ANHYDROUS may be tested according to a variety of international standards, such as European Pharmacopoeia (LEVOPROPOXYPHENE NAPSYLATE ANHYDROUS EP), LEVOPROPOXYPHENE NAPSYLATE ANHYDROUS JP (Japanese Pharmacopeia) and the US Pharmacopoeia (LEVOPROPOXYPHENE NAPSYLATE ANHYDROUS USP).
